NM_024079.5:c.1038+1G>T

Variant summary

Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PVS1PP5

The NM_024079.5(ALG8):​c.1038+1G>T variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000104 in 1,613,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

ALG8
NM_024079.5 splice_donor, intron

Scores

5
1
Splicing: ADA: 1.000
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1

Conservation

PhyloP100: 7.07

Publications

2 publications found
Variant links:
Genes affected
ALG8 (HGNC:23161): (ALG8 alpha-1,3-glucosyltransferase) This gene encodes a member of the ALG6/ALG8 glucosyltransferase family. The encoded protein catalyzes the addition of the second glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation of proteins. Mutations in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ih). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ALG8 Gene-Disease associations (from GenCC):
  • ALG8-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • polycystic liver disease 3 with or without kidney cysts
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 9 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PP5
Variant 11-78109441-C-A is Pathogenic according to our data. Variant chr11-78109441-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 492976.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024079.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG8
NM_024079.5
MANE Select
c.1038+1G>T
splice_donor intron
N/ANP_076984.2
ALG8
NM_001425224.1
c.1131+1G>T
splice_donor intron
N/ANP_001412153.1
ALG8
NM_001425225.1
c.1038+1G>T
splice_donor intron
N/ANP_001412154.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALG8
ENST00000299626.10
TSL:1 MANE Select
c.1038+1G>T
splice_donor intron
N/AENSP00000299626.5
ALG8
ENST00000679559.1
c.1038+1G>T
splice_donor intron
N/AENSP00000505433.1
ALG8
ENST00000532440.6
TSL:3
c.1038+1G>T
splice_donor intron
N/AENSP00000433429.2

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152132
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00170
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000263
AC:
66
AN:
251416
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00268
Gnomad NFE exome
AF:
0.0000616
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000101
AC:
148
AN:
1461860
Hom.:
0
Cov.:
32
AF XY:
0.000113
AC XY:
82
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00256
AC:
137
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000719
AC:
8
AN:
1111990
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152132
Hom.:
0
Cov.:
32
AF XY:
0.000202
AC XY:
15
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41426
American (AMR)
AF:
0.00
AC:
0
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00170
AC:
18
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000428
Hom.:
0
ExAC
AF:
0.000165
AC:
20

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Polycystic liver disease 3 with or without kidney cysts Pathogenic:1Uncertain:1
Feb 21, 2018
OMIM
Significance:Pathogenic
Review Status:flagged submission
Collection Method:literature only

Sep 19, 2023
MVZ Martinsried, Medicover Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Familial cystic renal disease Pathogenic:1
Jun 01, 2025
Mayo Translational Polycystic Kidney Disease Center, Mayo Clinic
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

The c.1038+1G>T variant in the ALG8 gene affects the invariant splice donor site of intron 10, a position critical for normal mRNA splicing. Alterations at this position are predicted to disrupt canonical splicing, likely resulting in aberrant transcripts and subsequent loss of function of the ALG8 protein. This variant has been previously reported in a patient with autosomal dominant polycystic liver disease (Besse et al., 2017), supporting its clinical relevance. Given that loss-of-function (LoF) is an established disease mechanism for ALG8-associated disorders, this variant satisfies PVS1. Additionally, it is extremely rare in population databases (allele frequency <0.01% in gnomAD v4.1.0), supporting PM2. Based on this evidence, the variant is classified as pathogenic.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.50
D
BayesDel_noAF
Pathogenic
0.44
CADD
Pathogenic
33
DANN
Uncertain
1.0
Eigen
Pathogenic
1.2
Eigen_PC
Pathogenic
1.1
FATHMM_MKL
Pathogenic
0.99
D
PhyloP100
7.1
GERP RS
5.7
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.94
SpliceAI score (max)
0.68
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.68
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202112771; hg19: chr11-77820487; COSMIC: COSV55199129; COSMIC: COSV55199129; API